|
1.
|
Hughes DJ, Kipar A, Leeming G, Sample JT, Stewart JP. Experimental infection of laboratory-bred bank voles (Myodes glareolus) with murid herpesvirus 4. Arch Virol. 2012 Nov; 157(11):2207-12.
|
|
|
|
|
2.
|
Stevens HC, Cham KS, Hughes DJ, Sun R, Sample JT, Bubb VJ, Stewart JP, Quinn JP. CTCF and Sp1 interact with the Murine gammaherpesvirus 68 internal repeat elements. Virus Genes. 2012 Oct; 45(2):265-73.
|
|
|
|
|
3.
|
Hughes DJ, Marendy EM, Dickerson CA, Yetming KD, Sample CE, Sample JT. Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency. J Virol. 2012 Jan; 86(2):1034-45.
|
|
|
|
|
4.
|
Hughes DJ, Dickerson CA, Shaner MS, Sample CE, Sample JT. trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency. J Virol. 2011 Nov; 85(21):11435-47.
|
|
|
|
|
5.
|
Hughes DJ, Kipar A, Leeming GH, Bennett E, Howarth D, Cummerson JA, Papoula-Pereira R, Flanagan BF, Sample JT, Stewart JP. Chemokine binding protein M3 of murine gammaherpesvirus 68 modulates the host response to infection in a natural host. PLoS Pathog. 2011 Mar; 7(3):e1001321.
|
|
|
|
|
6.
|
Hughes DJ, Kipar A, Sample JT, Stewart JP. Pathogenesis of a model gammaherpesvirus in a natural host. J Virol. 2010 Apr; 84(8):3949-61.
|
|
|
|
|
7.
|
Hughes DJ, Kipar A, Milligan SG, Cunningham C, Sanders M, Quail MA, Rajandream MA, Efstathiou S, Bowden RJ, Chastel C, Bennett M, Sample JT, Barrell B, Davison AJ, Stewart JP. Characterization of a novel wood mouse virus related to murid herpesvirus 4. J Gen Virol. 2010 Apr; 91(Pt 4):867-79.
|
|
|
|
|
8.
|
Ruf IK, Houmani JL, Sample JT. Epstein-Barr virus independent dysregulation of UBP43 expression alters interferon-stimulated gene expression in Burkitt lymphoma. PLoS One. 2009; 4(6):e6023.
|
|
|
|
|
9.
|
Garrison SP, Jeffers JR, Yang C, Nilsson JA, Hall MA, Rehg JE, Yue W, Yu J, Zhang L, Onciu M, Sample JT, Cleveland JL, Zambetti GP. Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol. 2008 Sep; 28(17):5391-402.
|
|
|
|
|
10.
|
Sample JT, Marendy EM, Hughes DJ, Sample CE. The EBV viral genome. In: Pipas JM, Damania B, eds. DNA tumor viruses. Springer. 2008; 241-258.
|
|
|
|
|
11.
|
Sample JT, Sample CE. Epstein-Barr virus: Molecular biology. In: Mahy BWJ, Van Regenmortel MHV, eds. Encyclopedia of virology, 3rd edition. Elsevier Ltd., Oxford. 2008; 157-167.
|
|
|
|
|
12.
|
Yoshioka M, Crum MM, Sample JT. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing. J Virol. 2008 Feb; 82(4):1679-87.
|
|
|
|
|
13.
|
Han Z, Marendy E, Wang YD, Yuan J, Sample JT, Swaminathan S. Multiple roles of Epstein-Barr virus SM protein in lytic replication. J Virol. 2007 Apr; 81(8):4058-69.
|
|
|
|
|
14.
|
Sample JT, Ruf IK. Burkitt lymphoma. In: Tselis A, Jenson HB, eds. Epstein-Barr virus. Taylor & Francis Group, LLC. 2006; 187-221.
|
|
|
|
|
15.
|
Ruf IK, Lackey KA, Warudkar S, Sample JT. Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR. J Virol. 2005 Dec; 79(23):14562-9.
|
|
|
|
|
16.
|
Macrae AI, Usherwood EJ, Husain SM, Flaño E, Kim IJ, Woodland DL, Nash AA, Blackman MA, Sample JT, Stewart JP. Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J Virol. 2003 Sep; 77(17):9700-9.
|
|
|
|
|
17.
|
Zhao B, Dalbiès-Tran R, Jiang H, Ruf IK, Sample JT, Wang F, Sample CE. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses. J Virol. 2003 May; 77(10):5639-48.
|
|
|
|
|
18.
|
Woodland DL, Flaño E, Usherwood EJ. Antigen expression during murine gamma-herpesvirus infection. Immunobiology. 2001 Dec; 204(5):649-58.
|
|
|
|
|
19.
|
Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT. EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma. Curr Top Microbiol Immunol. 2001; 258:153-60.
|
|
|
|
|
20.
|
Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol. 2000 Nov; 74(21):10223-8.
|
|
|
|
|
21.
|
Swart R, Ruf IK, Sample J, Longnecker R. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway. J Virol. 2000 Nov; 74(22):10838-45.
|
|
|
|
|
22.
|
Flaño E, Husain SM, Sample JT, Woodland DL, Blackman MA. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol. 2000 Jul 15; 165(2):1074-81.
|
|
|
|
|
23.
|
Ruf IK, Sample J. Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency. J Virol. 1999 Oct; 73(10):7943-51.
|
|
|
|
|
24.
|
Husain SM, Usherwood EJ, Dyson H, Coleclough C, Coppola MA, Woodland DL, Blackman MA, Stewart JP, Sample JT. Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc Natl Acad Sci U S A. 1999 Jun 22; 96(13):7508-13.
|
|
|
|
|
25.
|
Ruf IK, Moghaddam A, Wang F, Sample J. Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates. J Virol. 1999 Mar; 73(3):1980-9.
|
|
|
|
|
26.
|
Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT. Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol Cell Biol. 1999 Mar; 19(3):1651-60.
|
|
|
|
|
27.
|
Torii T, Konishi K, Sample J, Takada K. The truncated form of the Epstein-Barr virus LMP-1 is dispensable or complimentable by the full-length form in virus infection and replication. Virology. 1998 Nov 25; 251(2):273-8.
|
|
|
|
|
28.
|
Srinivas SK, Sample JT, Sixbey JW. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line. J Infect Dis. 1998 Jun; 177(6):1705-9.
|
|
|
|
|
29.
|
Chodosh J, Holder VP, Gan YJ, Belgaumi A, Sample J, Sixbey JW. Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype. J Infect Dis. 1998 May; 177(5):1194-201.
|
|
|
|
|
30.
|
Nonkwelo C, Ruf IK, Sample J. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma. J Virol. 1997 Sep; 71(9):6887-97.
|
|
|
|
|
31.
|
Nonkwelo C, Ruf IK, Sample J. The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element. J Virol. 1997 Jan; 71(1):354-61.
|
|
|
|
|
32.
|
Nonkwelo C, Skinner J, Bell A, Rickinson A, Sample J. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J Virol. 1996 Jan; 70(1):623-7.
|
|
|
|
|
33.
|
Nonkwelo C, Henson EB, Sample J. Characterization of the Epstein-Barr virus Fp promoter. Virology. 1995 Jan 10; 206(1):183-95.
|
|
|
|
|
34.
|
Sample J, Kieff EF, Kieff ED. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes. J Gen Virol. 1994 Oct; 75 ( Pt 10):2741-6.
|
|
|
|
|
35.
|
Sample J, Henson EB, Sample C. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol. 1992 Aug; 66(8):4654-61.
|
|
|
|
|
36.
|
Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson A, Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci U S A. 1991 Jul 15; 88(14):6343-7.
|
|
|
|
|
37.
|
Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol. 1990 Sep; 64(9):4084-92.
|
|
|
|
|
38.
|
Sample J, Kieff E. Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes. J Virol. 1990 Apr; 64(4):1667-74.
|
|
|
|
|
39.
|
Lieberman PM, Hardwick JM, Sample J, Hayward GS, Hayward SD. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J Virol. 1990 Mar; 64(3):1143-55.
|
|
|
|
|
40.
|
Birkenbach M, Liebowitz D, Wang F, Sample J, Kieff E. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines. J Virol. 1989 Sep; 63(9):4079-84.
|
|
|
|
|
41.
|
Sample J, Liebowitz D, Kieff E. Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J Virol. 1989 Feb; 63(2):933-7.
|
|
|
|
|
42.
|
Tanner J, Whang Y, Sample J, Sears A, Kieff E. Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J Virol. 1988 Dec; 62(12):4452-64.
|
|
|
|
|
43.
|
Heineman T, Gong M, Sample J, Kieff E. Identification of the Epstein-Barr virus gp85 gene. J Virol. 1988 Apr; 62(4):1101-7.
|
|
|
|
|
44.
|
Petti L, Sample J, Wang F, Kieff E. A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes. J Virol. 1988 Apr; 62(4):1330-8.
|
|
|
|
|
45.
|
Pearson GR, Luka J, Petti L, Sample J, Birkenbach M, Braun D, Kieff E. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology. 1987 Sep; 160(1):151-61.
|
|
|
|
|
46.
|
Liebowitz D, Kopan R, Fuchs E, Sample J, Kieff E. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol Cell Biol. 1987 Jul; 7(7):2299-308.
|
|
|
|
|
47.
|
Sample J, Hummel M, Braun D, Birkenbach M, Kieff E. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc Natl Acad Sci U S A. 1986 Jul; 83(14):5096-100.
|
|
|
|
|
48.
|
Sample J, Lancz G, Nonoyama M. Mapping of genes in BamHI fragment M of Epstein-Barr virus DNA that may determine the fate of viral infection. J Virol. 1986 Jan; 57(1):145-54.
|
|
|
|
|
49.
|
Lancz G, Sample J. Thermal-pH inactivation of herpes simplex virus: interdependence of the medium composition and the pH on the rate of virus inactivation. Brief report. Arch Virol. 1985; 84(1-2):141-6.
|
|
|
|
|
50.
|
Sample J, Tanaka A, Lancz G, Nonoyama M. Identification of Epstein-Barr virus genes expressed during the early phase of virus replication and during lymphocyte immortalization. Virology. 1984 Nov; 139(1):1-10.
|
|
|
|